Back to Search
Start Over
Adenoviral vector-mediated gene therapy for gliomas: coming of age
- Source :
- CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Publication Year :
- 2014
- Publisher :
- Taylor & Francis, 2014.
-
Abstract
- INTRODUCTION: Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults and it carries a dismal prognosis. Adenoviral vector (Ad)-mediated gene transfer is being developed as a promising therapeutic strategy for GBM. Preclinical studies have demonstrated safety and efficacy of adenovirus administration into the brain and tumor mass in rodents and into the non-human primates' brain. Importantly, Ads have been safely administered within the tumor resection cavity in humans. AREAS COVERED: This review gives background on GBM and Ads; we describe gene therapy strategies for GBM and discuss the value of combination approaches. Finally, we discuss the results of the human clinical trials for GBM that have used Ads. EXPERT OPINION: The transduction characteristics of Ads, and their safety profile, added to their capacity to achieve high levels of transgene expression have made them powerful vectors for the treatment of GBM. Recent gene therapy successes in the treatment of retinal diseases and systemic brain metabolic diseases encourage the development of gene therapy for malignant glioma. Exciting clinical trials are currently recruiting patients; although, it is the large randomized Phase III controlled clinical trials that will provide the final decision on the success of gene therapy for the treatment of GBM. Fil: Castro, María G.. University of Michigan; Estados Unidos Fil: Candolfi, Marianela. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina Fil: Wilson, Thomas J.. University of Michigan; Estados Unidos Fil: Calinescu, Alexandra. University of Michigan; Estados Unidos Fil: Paran, Christopher. University of Michigan; Estados Unidos Fil: Kamran, Neha. University of Michigan; Estados Unidos Fil: Koschmann, Carl. University of Michigan; Estados Unidos Fil: Moreno Ayala, Mariela Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina. Universidad de Buenos Aires. Facultad de Medicina; Argentina Fil: Assi, Hikmat. University Of Michigan Medical School; Fil: Lowenstein, Pedro R.. University of Michigan; Estados Unidos
- Subjects :
- CIENCIAS MÉDICAS Y DE LA SALUD
FMS-LIKE TYROSINE KINASE 3 LIGAND
Transgene
Genetic enhancement
medicine.medical_treatment
Genetic Vectors
Clinical Biochemistry
Biotecnología relacionada con la Salud
Brain tumor
GLIOBLASTOMA MULTIFORME
Bioinformatics
DENDRITIC CELLS
Article
Adenoviridae
Viral vector
Biotecnología de la Salud
Immunomodulation
Transduction (genetics)
HSV1-TK
FMS-like tyrosine kinase 3 ligand
Drug Discovery
Animals
Humans
Medicine
Transgenes
IMMUNOTHERAPY
purl.org/becyt/ford/3.4 [https]
Pharmacology
HIGH CAPACITY ADENOVIRUS
Brain Neoplasms
business.industry
Brain
Genetic Therapy
Glioma
Immunotherapy
medicine.disease
Clinical trial
Cancer research
purl.org/becyt/ford/3 [https]
Glioblastoma
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- CONICET Digital (CONICET), Consejo Nacional de Investigaciones Científicas y Técnicas, instacron:CONICET
- Accession number :
- edsair.doi.dedup.....e617accb928337da1cdc7c4e98063a93
- Full Text :
- https://doi.org/10.1517/14712598.2014.915307